{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:20:47Z","timestamp":1791991247548,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.suronc.2020.08.015","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T02:42:17Z","timestamp":1597891337000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-4289","authenticated-orcid":false,"given":"Francesco","family":"Panzuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-8192","authenticated-orcid":false,"given":"Sara","family":"Massironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rinzivillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Andreasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3069-7630","authenticated-orcid":false,"given":"Giuseppe","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9654-7243","authenticated-orcid":false,"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2020.08.015_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.23549","article-title":"Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors","volume":"113","author":"Pape","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2020.08.015_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000494355","article-title":"Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study","volume":"107","author":"Rindi","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.pan.2019.09.015","article-title":"Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: a comparison between pancreatic and gastrointestinal localizations","volume":"19","author":"Panzuto","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2020.08.015_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MED.0b013e32835570f1","article-title":"A rationale for multidisciplinary care in treating neuroendocrine tumours","volume":"19","author":"Metz","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.suronc.2020.08.015_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060910","article-title":"Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center","volume":"8","author":"Magi","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.suronc.2020.08.015_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0016-5085(99)70174-5","article-title":"ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis","volume":"116","author":"Rindi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suronc.2020.08.015_bib8","series-title":"Digestive System Tumours","article-title":"WHO classification of tumours","author":"Board WC of TE","year":"2019"},{"key":"10.1016\/j.suronc.2020.08.015_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000329043","article-title":"Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate","volume":"95","author":"Merola","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-12-0836","article-title":"Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study","volume":"168","author":"Thomas","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.suronc.2020.08.015_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10620-014-3410-1","article-title":"Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience","volume":"60","author":"Chen","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.suronc.2020.08.015_bib12","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","article-title":"Metastatic type 1 gastric carcinoid: a real threat or just a myth?","volume":"19","author":"Grozinsky-Glasberg","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.suronc.2020.08.015_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.advms.2015.10.001","article-title":"Ki-67 prognostic and therapeutic decision driven marker for pancreatic neuroendocrine neoplasms (PNENs): a systematic review","volume":"61","author":"Pezzilli","year":"2016","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.suronc.2020.08.015_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000334038","article-title":"Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors","volume":"96","author":"Panzuto","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000502776","article-title":"Classification and prognostic stratification of bronchopulmonary neuroendocrine neoplasms","volume":"110","author":"Oka","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000489902","article-title":"Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: analysis of 200 cases with extended follow-up","volume":"107","author":"Vanoli","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12020-015-0584-z","article-title":"Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study","volume":"51","author":"Campana","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.suronc.2020.08.015_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.dld.2019.04.016","article-title":"Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study","volume":"51","author":"Panzuto","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.suronc.2020.08.015_bib19","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00042737-200112000-00008","article-title":"Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid","volume":"13","author":"Annibale","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.suronc.2020.08.015_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/00365521.2015.1010570","article-title":"Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up","volume":"50","author":"Lahner","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.suronc.2020.08.015_bib21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.dld.2019.09.016","article-title":"Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian society of hospital gastroenterologists and digestive endoscopists [AIGO], the Italian society of digestive endoscopy [SIED], the Italian so","volume":"51","author":"Lahner","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.suronc.2020.08.015_bib22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/hupa.2001.28955","article-title":"Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison","volume":"32","author":"Bornstein-Quevedo","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.suronc.2020.08.015_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00423-001-0260-z","article-title":"Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy","volume":"386","author":"Witzigmann","year":"2002","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1091-255X(03)00114-8","article-title":"Ampullary carcinoid tumors: rationale for an aggressive surgical approach","volume":"7","author":"Clements","year":"2003","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1440-1746.2005.03744.x","article-title":"Carcinoid of the ampulla of vater","volume":"20","author":"Hartel","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.suronc.2020.08.015_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11605-013-2365-4","article-title":"Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study","volume":"18","author":"Randle","year":"2014","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib27","first-page":"700","article-title":"Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases","volume":"114","author":"Burke","year":"1990","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.suronc.2020.08.015_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1241::AID-CNCR5>3.0.CO;2-4","article-title":"Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors","volume":"85","author":"Makhlouf","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2020.08.015_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archsurg.2009.80","article-title":"Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management","volume":"144","author":"Carter","year":"2009","journal-title":"Arch. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000459619","article-title":"The risk factors for metastasis in non-ampullary duodenal neuroendocrine tumors measuring 20 mm or less in diameter","volume":"95","author":"Hatta","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.suronc.2020.08.015_bib31","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1245\/s10434-018-6673-5","article-title":"Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience","volume":"25","author":"Massironi","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444803","article-title":"Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases","volume":"104","author":"Vanoli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib33","article-title":"Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: a retrospective, single-center study","volume":"98","author":"Park","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.suronc.2020.08.015_bib34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00365521.2018.1468479","article-title":"Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity","volume":"53","author":"Rossi","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.suronc.2020.08.015_bib35","article-title":"Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): a multicenter retrospective study","volume":"98","author":"Lee","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.suronc.2020.08.015_bib36","article-title":"Management and prognosis of localized duodenal neuroendocrine neoplasms","author":"Gay-Chevallier","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.suronc.2020.08.015_bib38","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1245\/s10434-013-3005-7","article-title":"Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size","volume":"20","author":"Kuo","year":"2013","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF01297144","article-title":"Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases","volume":"36","author":"Kimura","year":"1991","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.suronc.2020.08.015_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabres.2012.08.007","article-title":"Asymptomatic insulinoma: a case report and autopsy series","volume":"98","author":"Kishi","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.suronc.2020.08.015_bib41","doi-asserted-by":"crossref","DOI":"10.1159\/000499606","article-title":"Is the real prevalence of pancreatic neuroendocrine tumors underestimated? A retrospective study on a large series of pancreatic specimens","author":"Partelli","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2013.3376","article-title":"Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)","author":"Partelli","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suronc.2020.08.015_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14701\/ahbps.2018.22.1.66","article-title":"Prognostic factors of non-functioning pancreatic neuroendocrine tumor revisited: the value of WHO 2010 classification","volume":"22","author":"Bu","year":"2018","journal-title":"Ann Hepato-Biliary-Pancreatic Surg"},{"key":"10.1016\/j.suronc.2020.08.015_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijsu.2019.12.034","article-title":"Novel scoring system for recurrence risk classification of surgically resected G1\/2 pancreatic neuroendocrine tumors - retrospective cohort study","volume":"74","author":"Zou","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.suronc.2020.08.015_bib46","series-title":"AJCC Cancer Staging Manual. Eighth Edi","year":"2017"},{"key":"10.1016\/j.suronc.2020.08.015_bib47","doi-asserted-by":"crossref","DOI":"10.4103\/0366-6999.171427","article-title":"Impact and clinical predictors of lymph node metastases in nonfunctional pancreatic neuroendocrine tumors","author":"Jiang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.suronc.2020.08.015_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003461","article-title":"A novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an international study of 1006 patients","author":"Zaidi","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib49","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1245\/s10434-019-07367-y","article-title":"Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: an eight-institution study of 695 patients from the US neuroendocrine tumor study group","volume":"26","author":"Lopez-Aguiar","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.surg.2011.02.022","article-title":"Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor","volume":"150","author":"Bettini","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.dld.2019.01.008","article-title":"The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age","volume":"51","author":"Partelli","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.suronc.2020.08.015_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000464292","article-title":"ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours","volume":"105","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The north American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.suronc.2020.08.015_bib55","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.surg.2015.04.035","article-title":"Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: do size and symptoms matter?","volume":"158","author":"Sallinen","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib56","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejso.2014.06.004","article-title":"Pancreatic neuroendocrine tumor: a multivariate analysis of factors influencing survival","volume":"40","author":"Birnbaum","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hpb.2017.08.034","article-title":"Prognosis of sporadic resected small (<\/=2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study","volume":"20","author":"Sallinen","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.suronc.2020.08.015_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2019.04.003","article-title":"Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life","author":"Partelli","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1148\/radiol.10100046","article-title":"Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?","volume":"257","author":"Shi","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.suronc.2020.08.015_bib60","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.pan.2018.08.004","article-title":"Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms","volume":"18","author":"Massironi","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.suronc.2020.08.015_bib61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","article-title":"Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management","volume":"152","author":"Lee","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib62","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/jc.2013-2604","article-title":"Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors","volume":"98","author":"Gaujoux","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.suronc.2020.08.015_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bjs.10312","article-title":"Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms","volume":"104","author":"Partelli","year":"2017","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib64","article-title":"Resection versus observation of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors","author":"Barenboim","year":"2019","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib65","article-title":"Surgery versus surveillance for well\u2010differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11\u2010year analysis of the national cancer database","author":"Assi","year":"2019","journal-title":"Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib66","article-title":"A survival analysis of patients with localized, asymptomatic pancreatic neuroendocrine tumors: No surgical survival benefit when examining appropriately selected outcomes","author":"Powers","year":"2019","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib67","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ejca.2011.10.030","article-title":"Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections","volume":"48","author":"Boninsegna","year":"2012","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.suronc.2020.08.015_bib68","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1245\/s10434-018-6518-2","article-title":"Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67","volume":"25","author":"Genc","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.surg.2019.03.008","article-title":"The conundrum of < 2-cm pancreatic neuroendocrine tumors: a preoperative risk score to predict lymph node metastases and guide surgical management","volume":"166","author":"Lopez-Aguiar","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib70","series-title":"WHO Classification of Tumours of Endocrine Organs","year":"2017"},{"key":"10.1016\/j.suronc.2020.08.015_bib71","article-title":"Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases","author":"Pea","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib72","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1038\/s41598-019-55156-0","article-title":"DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors","volume":"9","author":"Cives","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.suronc.2020.08.015_bib73","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/ajg.2010.341","article-title":"Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971","volume":"105","author":"Ellis","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.suronc.2020.08.015_bib74","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.canep.2011.05.011","article-title":"Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004","volume":"35","author":"Alsina","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.suronc.2020.08.015_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jso.21888","article-title":"Carcinoid tumors of the appendix: a population-based study","volume":"104","author":"Mullen","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000478742","article-title":"Surgical management of patients with neuroendocrine neoplasms of the appendix: appendectomy or more","volume":"106","author":"Pawa","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.21764","article-title":"Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival","volume":"103","author":"Groth","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib78","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10350-005-0196-4","article-title":"Malignancies of the appendix: beyond case series reports","volume":"48","author":"McGory","year":"2005","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.suronc.2020.08.015_bib79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/DCR.0000000000000852","article-title":"Mesenteric lymphadenectomy in well-differentiated appendiceal neuroendocrine tumors","volume":"60","author":"Raoof","year":"2017","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.suronc.2020.08.015_bib80","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib81","first-page":"1","article-title":"Challenging the current risk factors of appendiceal neuroendocrine neoplasms: can they accurately predict local lymph nodal invasion? Results from a large case series","author":"Galanopoulos","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SLA.0000000000002736","article-title":"Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a national study from the French group of endocrine tumors (GTE)","volume":"270","author":"Rault-Petit","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib83","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/SLA.0000000000003077","article-title":"Comment on \u201ccurrent management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors\u201d: a national study from the French group of endocrine tumors (gte)","volume":"270","author":"Lamberti","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib84","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0000000000002939","article-title":"Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study","volume":"271","author":"Brighi","year":"2020","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00000658-197907000-00013","article-title":"Carcinoid tumors of the appendix. Mesoappendiceal extension and nodal metastases","volume":"190","author":"Syracuse","year":"1979","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib86","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PAS.0b013e318275d1d7","article-title":"Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases","volume":"37","author":"Volante","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.suronc.2020.08.015_bib87","first-page":"1","article-title":"Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis","author":"Ricci","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.suronc.2020.08.015_bib88","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.13697","article-title":"Review article: the investigation and management of rectal neuroendocrine tumours","volume":"44","author":"Basuroy","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.suronc.2020.08.015_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000355612","article-title":"Clinical and prognostic features of rectal neuroendocrine tumors","volume":"98","author":"Weinstock","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib90","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11605-011-1786-1","article-title":"Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection","volume":"16","author":"Al Natour","year":"2012","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2020.08.015_bib91","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.surg.2013.11.012","article-title":"Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification","volume":"155","author":"Lee","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2020.08.015_bib92","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.gie.2018.11.010","article-title":"Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors","volume":"89","author":"Ngamruengphong","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.suronc.2020.08.015_bib93","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1055\/s-0033-1344794","article-title":"Updating the management of patients with rectal neuroendocrine tumors","volume":"45","author":"de Mestier","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.suronc.2020.08.015_bib94","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1055\/s-0030-1256414","article-title":"Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread","volume":"43","author":"Park","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.suronc.2020.08.015_bib95","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1440-1746.2012.07218.x","article-title":"Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution","volume":"27","author":"Kasuga","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.suronc.2020.08.015_bib96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10350-004-0765-y","article-title":"Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography","volume":"48","author":"Kobayashi","year":"2005","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.suronc.2020.08.015_bib97","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00464-009-0791-x","article-title":"Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors","volume":"24","author":"Ishii","year":"2010","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.suronc.2020.08.015_bib98","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gie.2013.11.031","article-title":"Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes","volume":"80","author":"Gleeson","year":"2014","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.suronc.2020.08.015_bib99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ctrv.2018.04.003","article-title":"Neuroendocrine neoplasms of rectum: a management update","volume":"66","author":"Bertani","year":"2018","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.suronc.2020.08.015_bib100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-016-0923-4","article-title":"Endoscopic submucosal dissection versus transanal local excision for rectal carcinoid: a comparative study","volume":"14","author":"Yan","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.08.015_bib101","doi-asserted-by":"crossref","DOI":"10.1159\/000443166","article-title":"ENETS consensus guidelines update for colorectal neuroendocrine neoplasms","author":"Ramage","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.suronc.2020.08.015_bib102","first-page":"419","article-title":"Italian association of clinical endocrinologists (AME) and Italian AACE chapter position statement for clinical practice: assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Grimaldi","year":"2018","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420303650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420303650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:18:33Z","timestamp":1760757513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740420303650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":102,"alternative-id":["S0960740420303650"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2020.08.015","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2020.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}